COMPARE · Data as of August 24, 2026
DOCS vs OMCL
Verdict: Side-by-side breakdown using the Bull Rankings model. DOCS scored 84.2, OMCL scored 52.6 — DOCS leads.
Compare another set
DOCS
Doximity, Inc.
84.2
$25.30 · $4.5B
fundamentals as of
Score gap
31.6
DOCS leads
OMCL
Omnicell, Inc.
52.6
$34.66 · $1.6B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestDOCS30.1x
- Fastest growthDOCS+11.2%
- Strongest balance sheetDOCS0.01
- Highest qualityDOCS89 / 100
- Largest discount to fair valueOMCL-11%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
DOCS
stronger →← stronger
OMCL
89
Qualityreturns · margins · balance sheet
48
85
Growthrevenue & earnings expansion
59
79
Valuevaluation vs sector peers
51
DOCS is stronger on 3 of 3 pillars.
Fundamentals, head-to-head
DOCS
OMCL
$306mC
FCF
$143mC
+11.2%B
Rev
+8.5%B
0.01A-
D/E
0.15B+
30.1xB
P/E
42.3xC
0.59A-
PEG
15.40D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
DOCS
OMCL
9% below
Price vs fair valuelower is cheaper
11% below
~7%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-4%/yr
-5%
1-yr DCF upside
+25%
+10%
5-yr DCF upside
+13%
+35%
10-yr DCF upside
-3%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
DOCS
Why this score
- Durable high returns
OMCL
No notable signals flagged.
The companies
DOCSDoximity, Inc.
Why now
Health Information Services · market cap $4.5b. Down 67% from 52-week high of $76.51 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. PEG 0.59 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Hold with a mean 1-yr target of $29.78 (implying +18% upside).
Moat
Net margin 25% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 67% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 30x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
OMCLOmnicell, Inc.
Why now
Health Information Services · market cap $1.6b. Down 37% from 52-week high of $55.00 — deep drawdown territory. 7 sell-side analysts publish a mean 1-yr target of $57.86 (implying +67% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 42x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where DOCS and OMCL diverge
On the headline score the gap is 31.6 points in favor of DOCS. The widest single difference is Quality, where DOCS leads by 41.1 points.
- QualityDOCS 88.6 · OMCL 47.5DOCS +41.1
- ValueDOCS 79.3 · OMCL 51.4DOCS +27.9
- GrowthDOCS 85.0 · OMCL 59.5DOCS +25.5
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.